GEN vs CPAY

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

GEN

34.3
AI Score
VS
GEN Wins

CPAY

33.8
AI Score

Investment Advisor Scores

GEN

34score
Recommendation
EXTENDED

CPAY

34score
Recommendation
EXTENDED

AI Analyst Insights

Detailed Metrics Comparison

Metric GEN CPAY Winner
Forward P/E 10.0908 14.7929 GEN
PEG Ratio 1.771 0.8697 CPAY
Revenue Growth 12.2% 17.9% CPAY
Earnings Growth 128.6% 44.8% GEN
Tradestie Score 34.3/100 33.8/100 GEN
Profit Margin 23.1% 23.7% CPAY
Beta 1.00 1.00 Tie
AI Recommendation EXTENDED EXTENDED Tie

Relative Price Performance (Last 90 Days)

GEN 1M: +27.6% · 3M: +2.7% CPAY 1M: +15.2% · 3M: +8.1%

Current Technical Phase

GEN

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 69

RSI (14): 69.1 · Price: $30.38

CPAY

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (1.0% over 20 days), RSI 77

RSI (14): 77.2 · Price: $459.65

Fundamentals Snapshot

Metric GEN CPAY
Market Cap — —
Forward P/E 10.5 14.5
Trailing P/E 15.1 25.0
Revenue (TTM) — —
Revenue Growth 0.1% 0.2%
Gross Margin 0.8% 0.8%
Operating Margin 0.4% 0.5%
EPS 1.97 18.30
Dividend Yield 0.02% —

Frequently Asked Questions

Based on our detailed analysis, GEN is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.